United States Bioactive Substances Market Report 2016

October 2016 | 115 pages | ID: UD095E56885EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Bioactive Substances

Revenue, means the sales value of Bioactive Substances

This report studies sales (consumption) of Bioactive Substances in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• BASF SE (Germany)
• CP Kelco (US)
• Cyanotech Corp. (US)
• Nutrex Hawaii (US)
• FMC Health and Nutrition (US)
• NovaMatrix (Norway)
• GlycoMar Ltd. (UK)
• Jazz Pharmaceuticals plc (Ireland)
• Lonza Group Ltd. (Switzerland)
• Marinova Pty Ltd (Australia)
• New England Biolabs Inc (US)
• oceanBASIS GmbH (Germany)
• PharmaMar S.A (Spain)
• PML Applications Ltd. (UK)
• Prolume Ltd (US)
• BioLume(r), Inc. (US)
• Royal DSM N.V (Netherlands)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Bioactive Substances in each application, can be divided into

• Foods
• Nutraceuticals
• Medicine
• Cosmetics
• Research Tools
• Processing Technologies
• New Energy Sources
• Agriculture
• Industrial
• Food Safety

Contents

United States Bioactive Substances Market Report 2016

1 BIOACTIVE SUBSTANCES OVERVIEW

1.1 Product Overview and Scope of Bioactive Substances
1.2 Classification of Bioactive Substances
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Bioactive Substances
  1.3.1 Foods
  1.3.2 Nutraceuticals
  1.3.3 Medicine
  1.3.4 Cosmetics
  1.3.5 Research Tools
  1.3.6 Processing Technologies
  1.3.7 New Energy Sources
  1.3.8 Agriculture
  1.3.9 Industrial
  1.3.10 Food Safety
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Bioactive Substances (2011-2021)
  1.4.1 United States Bioactive Substances Sales and Growth Rate (2011-2021)
  1.4.2 United States Bioactive Substances Revenue and Growth Rate (2011-2021)

2 UNITED STATES BIOACTIVE SUBSTANCES COMPETITION BY MANUFACTURERS

2.1 United States Bioactive Substances Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Bioactive Substances Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Bioactive Substances Average Price by Manufactures (2015 and 2016)
2.4 Bioactive Substances Market Competitive Situation and Trends
  2.4.1 Bioactive Substances Market Concentration Rate
  2.4.2 Bioactive Substances Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BIOACTIVE SUBSTANCES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Bioactive Substances Sales and Market Share by Type (2011-2016)
3.2 United States Bioactive Substances Revenue and Market Share by Type (2011-2016)
3.3 United States Bioactive Substances Price by Type (2011-2016)
3.4 United States Bioactive Substances Sales Growth Rate by Type (2011-2016)

4 UNITED STATES BIOACTIVE SUBSTANCES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Bioactive Substances Sales and Market Share by Application (2011-2016)
4.2 United States Bioactive Substances Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES BIOACTIVE SUBSTANCES MANUFACTURERS PROFILES/ANALYSIS

5.1 BASF SE (Germany)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Bioactive Substances Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 BASF SE (Germany) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 CP Kelco (US)
  5.2.2 Bioactive Substances Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 CP Kelco (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Cyanotech Corp. (US)
  5.3.2 Bioactive Substances Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Cyanotech Corp. (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Nutrex Hawaii (US)
  5.4.2 Bioactive Substances Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Nutrex Hawaii (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 FMC Health and Nutrition (US)
  5.5.2 Bioactive Substances Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 FMC Health and Nutrition (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 NovaMatrix (Norway)
  5.6.2 Bioactive Substances Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 NovaMatrix (Norway) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 GlycoMar Ltd. (UK)
  5.7.2 Bioactive Substances Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 GlycoMar Ltd. (UK) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Jazz Pharmaceuticals plc (Ireland)
  5.8.2 Bioactive Substances Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Lonza Group Ltd. (Switzerland)
  5.9.2 Bioactive Substances Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Lonza Group Ltd. (Switzerland) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Marinova Pty Ltd (Australia)
  5.10.2 Bioactive Substances Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Marinova Pty Ltd (Australia) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 New England Biolabs Inc (US)
5.12 oceanBASIS GmbH (Germany)
5.13 PharmaMar S.A (Spain)
5.14 PML Applications Ltd. (UK)
5.15 Prolume Ltd (US)
5.16 BioLume(r), Inc. (US)
5.17 Royal DSM N.V (Netherlands)

6 BIOACTIVE SUBSTANCES MANUFACTURING COST ANALYSIS

6.1 Bioactive Substances Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Bioactive Substances

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Bioactive Substances Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Bioactive Substances Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES BIOACTIVE SUBSTANCES MARKET FORECAST (2016-2021)

10.1 United States Bioactive Substances Sales, Revenue Forecast (2016-2021)
10.2 United States Bioactive Substances Sales Forecast by Type (2016-2021)
10.3 United States Bioactive Substances Sales Forecast by Application (2016-2021)
10.4 Bioactive Substances Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bioactive Substances
Table Classification of Bioactive Substances
Figure United States Sales Market Share of Bioactive Substances by Type in 2015
Table Application of Bioactive Substances
Figure United States Sales Market Share of Bioactive Substances by Application in 2015
Figure Foods Examples
Figure Nutraceuticals Examples
Figure Medicine Examples
Figure Cosmetics Examples
Figure Research Tools Examples
Figure Processing Technologies Examples
Figure New Energy Sources Examples
Figure Agriculture Examples
Figure Industrial Examples
Figure Food Safety Examples
Figure United States Bioactive Substances Sales and Growth Rate (2011-2021)
Figure United States Bioactive Substances Revenue and Growth Rate (2011-2021)
Table United States Bioactive Substances Sales of Key Manufacturers (2015 and 2016)
Table United States Bioactive Substances Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bioactive Substances Sales Share by Manufacturers
Figure 2016 Bioactive Substances Sales Share by Manufacturers
Table United States Bioactive Substances Revenue by Manufacturers (2015 and 2016)
Table United States Bioactive Substances Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Bioactive Substances Revenue Share by Manufacturers
Table 2016 United States Bioactive Substances Revenue Share by Manufacturers
Table United States Market Bioactive Substances Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Bioactive Substances Average Price of Key Manufacturers in 2015
Figure Bioactive Substances Market Share of Top 3 Manufacturers
Figure Bioactive Substances Market Share of Top 5 Manufacturers
Table United States Bioactive Substances Sales by Type (2011-2016)
Table United States Bioactive Substances Sales Share by Type (2011-2016)
Figure United States Bioactive Substances Sales Market Share by Type in 2015
Table United States Bioactive Substances Revenue and Market Share by Type (2011-2016)
Table United States Bioactive Substances Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Bioactive Substances by Type (2011-2016)
Table United States Bioactive Substances Price by Type (2011-2016)
Figure United States Bioactive Substances Sales Growth Rate by Type (2011-2016)
Table United States Bioactive Substances Sales by Application (2011-2016)
Table United States Bioactive Substances Sales Market Share by Application (2011-2016)
Figure United States Bioactive Substances Sales Market Share by Application in 2015
Table United States Bioactive Substances Sales Growth Rate by Application (2011-2016)
Figure United States Bioactive Substances Sales Growth Rate by Application (2011-2016)
Table BASF SE (Germany) Basic Information List
Table BASF SE (Germany) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Figure BASF SE (Germany) Bioactive Substances Sales Market Share (2011-2016)
Table CP Kelco (US) Basic Information List
Table CP Kelco (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table CP Kelco (US) Bioactive Substances Sales Market Share (2011-2016)
Table Cyanotech Corp. (US) Basic Information List
Table Cyanotech Corp. (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cyanotech Corp. (US) Bioactive Substances Sales Market Share (2011-2016)
Table Nutrex Hawaii (US) Basic Information List
Table Nutrex Hawaii (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Nutrex Hawaii (US) Bioactive Substances Sales Market Share (2011-2016)
Table FMC Health and Nutrition (US) Basic Information List
Table FMC Health and Nutrition (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table FMC Health and Nutrition (US) Bioactive Substances Sales Market Share (2011-2016)
Table NovaMatrix (Norway) Basic Information List
Table NovaMatrix (Norway) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table NovaMatrix (Norway) Bioactive Substances Sales Market Share (2011-2016)
Table GlycoMar Ltd. (UK) Basic Information List
Table GlycoMar Ltd. (UK) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlycoMar Ltd. (UK) Bioactive Substances Sales Market Share (2011-2016)
Table Jazz Pharmaceuticals plc (Ireland) Basic Information List
Table Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jazz Pharmaceuticals plc (Ireland) Bioactive Substances Sales Market Share (2011-2016)
Table Lonza Group Ltd. (Switzerland) Basic Information List
Table Lonza Group Ltd. (Switzerland) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Group Ltd. (Switzerland) Bioactive Substances Sales Market Share (2011-2016)
Table Marinova Pty Ltd (Australia) Basic Information List
Table Marinova Pty Ltd (Australia) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marinova Pty Ltd (Australia) Bioactive Substances Sales Market Share (2011-2016)
Table New England Biolabs Inc (US) Basic Information List
Table New England Biolabs Inc (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs Inc (US) Bioactive Substances Sales Market Share (2011-2016)
Table oceanBASIS GmbH (Germany) Basic Information List
Table oceanBASIS GmbH (Germany) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table oceanBASIS GmbH (Germany) Bioactive Substances Sales Market Share (2011-2016)
Table PharmaMar S.A (Spain) Basic Information List
Table PharmaMar S.A (Spain) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table PharmaMar S.A (Spain) Bioactive Substances Sales Market Share (2011-2016)
Table PML Applications Ltd. (UK) Basic Information List
Table PML Applications Ltd. (UK) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table PML Applications Ltd. (UK) Bioactive Substances Sales Market Share (2011-2016)
Table Prolume Ltd (US) Basic Information List
Table Prolume Ltd (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prolume Ltd (US) Bioactive Substances Sales Market Share (2011-2016)
Table BioLume(r), Inc. (US) Basic Information List
Table BioLume(r), Inc. (US) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table BioLume(r), Inc. (US) Bioactive Substances Sales Market Share (2011-2016)
Table Royal DSM N.V (Netherlands) Basic Information List
Table Royal DSM N.V (Netherlands) Bioactive Substances Sales, Revenue, Price and Gross Margin (2011-2016)
Table Royal DSM N.V (Netherlands) Bioactive Substances Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bioactive Substances
Figure Manufacturing Process Analysis of Bioactive Substances
Figure Bioactive Substances Industrial Chain Analysis
Table Raw Materials Sources of Bioactive Substances Major Manufacturers in 2015
Table Major Buyers of Bioactive Substances
Table Distributors/Traders List
Figure United States Bioactive Substances Production and Growth Rate Forecast (2016-2021)
Figure United States Bioactive Substances Revenue and Growth Rate Forecast (2016-2021)
Table United States Bioactive Substances Production Forecast by Type (2016-2021)
Table United States Bioactive Substances Consumption Forecast by Application (2016-2021)